E-LIB Suche - Ergebnisse für: Davis, Matthew R

1

Things We Do for No Reason – Ordering Streptococcus Pneumon..:

Davis, Matthew R ; McCreary, Erin K ; Trzebucki, Alex M
Open Forum Infectious Diseases. 11 (2024) 3 - p. , 2024

2

Impact of a pharmacy-driven MRSA nares screening protocol o..:

Trzebucki, Alex M. ; Davis, Matthew R. ; McCreary, Erin K....
Antimicrobial Stewardship & Healthcare Epidemiology. 4 (2024) 1 - p. , 2024

Link: https://doi.org/10.1017/..

3

136. Impact of a Tele-Stewardship and Tele-Infection Preven..:

Davis, Matthew R ; Trzebucki, Alex ; McCreary, Erin K..
Open Forum Infectious Diseases. 10 (2023) Supplement_2 - p. , 2023

Link: https://doi.org/10.1093/..

4

Healthcare Costs in Men with Metastatic Castration-Resistan..:

Freedland, Stephen J. ; Davis, Matthew R. ; Epstein, Andrew J...
Advances in Therapy. 40 (2023) 10 - p. 4480-4492 , 2023

Link: https://doi.org/10.1007/..

5

Utility of triazole antifungal therapeutic drug monitoring:..:

McCreary, Erin K. ; Davis, Matthew R. ; Narayanan, Navaneeth...
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 43 (2023) 10 - p. 1043-1050 , 2023

Link: https://doi.org/10.1002/..

6

Enteral feeding tube administration with therapeutic drug m..:

Dieringer, Thomas D. ; Schaenman, Joanna M. ; Davis, Matthew R.
Journal of Antimicrobial Chemotherapy. , 2022

Link: https://doi.org/10.1093/..

7

Isavuconazole for treatment of refractory coccidioidal meni..:

Davis, Matthew R ; Chang, Sandy ; Gaynor, Pryce..
Medical Mycology. 59 (2021) 9 - p. 939-942 , 2021

Link: https://doi.org/10.1093/..

8

A review of remdesivir for COVID-19 in pregnancy and lactat..:

Jorgensen, Sarah C J ; Davis, Matthew R ; Lapinsky, Stephen E
Journal of Antimicrobial Chemotherapy. 77 (2021) 1 - p. 24-30 , 2021

Link: https://doi.org/10.1093/..

9

225. Risk Factors for Mortality in Stenotrophomonas Bactere..:

Huang, Glen ; Davis, Matthew R ; Allyn, Paul R
Open Forum Infectious Diseases. 8 (2021) Supplement_1 - p. S220-S220 , 2021

Link: https://doi.org/10.1093/..

10

67. Agreement Among Bayesian Dosing Software for Calculatin..:

Pineda, Ross ; Kanatani, Meganne ; Davis, Matthew R...
Open Forum Infectious Diseases. 8 (2021) Supplement_1 - p. S45-S45 , 2021

Link: https://doi.org/10.1093/..

11

Achievement of clinical isavuconazole blood concentrations ..:

McCreary, Erin K ; Nguyen, M Hong ; Davis, Matthew R...
Journal of Antimicrobial Chemotherapy. 75 (2020) 10 - p. 3023-3028 , 2020

Link: https://doi.org/10.1093/..

12

That Escalated Quickly: Remdesivir's Place in Therapy for C..:

Davis, Matthew R. ; McCreary, Erin K. ; Pogue, Jason M.
Infectious Diseases and Therapy. 9 (2020) 3 - p. 525-536 , 2020

Link: https://doi.org/10.1007/..

13

1109. Valgancyclovir Dosing for Cytomegalovirus Prophylaxis..:

Huang, Glen ; Davis, Matthew R ; Beaird, Omer E...
Open Forum Infectious Diseases. 7 (2020) Supplement_1 - p. S584-S585 , 2020

Link: https://doi.org/10.1093/..

14

752. Management of 20 Patients Diagnosed with Posaconazole-..:

Gintjee, Thomas J ; Davis, Matthew R ; Nguyen, Minh-Vu Hoang...
Open Forum Infectious Diseases. 7 (2020) Supplement_1 - p. S423-S424 , 2020

Link: https://doi.org/10.1093/..

15

Remdesivir and GS-441524 plasma concentrations in patients ..:

Davis, Matthew R ; Pham, Christine U ; Cies, Jeffrey J
Journal of Antimicrobial Chemotherapy. 76 (2020) 3 - p. 822-825 , 2020

Link: https://doi.org/10.1093/..